No Disruption in Supply as Recordati Takes Over Sales of Signifor

The Cushing’s drugs Signofor and Signifor LAR are now going to be marketed in the U.S. by Recordati, which purchased the rights from Novartis last year. The company says there will be no disruption in supply and the new company will offer a program to subsidize the drugs for low-income families. Read the article here:


Available Now!

PPRG6-500 Cover
The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.

Buy Now

Continuing Education Program

Knowledge Icon 500

If you are a nurse or medical professional, register for PNA CEU Membership and  earn CEU credits to learn about the symptoms, diagnosis and treatment options for patients with pituitary disorders. Help PNA reduce the time it takes for patients to get an accurate diagnosis.

button registerNow

For more information click here!